However, HF-fed AOiGHD exhibit impaired glucose clearance, despite improved insulin sensitivity, where circulating insulin levels and whole pancreatic INS-2 transcript remained inappropriately low, compared to GH-intact controls. The gene discussed is INS; the disease is hydrops fetalis.